|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Sep 30, 2022
|
FY2021
12 months to Sep 30, 2021
|
|
|---|---|---|---|---|---|
| Operating expenses | |||||
| General and administrative | |||||
| Research and development | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Other income (expense) | |||||
| Grant income | |||||
| Research and development incentive income | |||||
| Interest income, net | |||||
| Other financing expense | |||||
| Foreign exchange gain (loss) | |||||
| Total other income, net | |||||
| Net loss before provision for income taxes | |||||
| Income tax expense, current | |||||
| Net Income (Loss) | |||||
| Net Loss per share, Basic | |||||
| Net Loss per share, Diluted | |||||
| Weighted average number of shares outstanding, Basic | |||||
| Weighted average number of shares outstanding, Diluted | |||||
Loading...